Skip to main content

and
  1. No Access

    Article

    Amniotic Mesenchymal Stem Cells Decrease Aβ Deposition and Improve Memory in APP/PS1 Transgenic Mice

    Transplantation of human amniotic mesenchymal stem cells (hAM-MSCs) seems to be a promising strategy for the treatment of neurodegenerative disorders, including Alzheimer’s disease (AD). However, the clinical ...

    **ao-Yu Zheng, Qian-Quan Wan, Chuan-Yi Zheng, Hong-Long Zhou in Neurochemical Research (2017)